论文信息 - Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study - 字舞流文

Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study

M. Tomasson | S. Iida | M. Mohty | A. Lesokhin | N. Raje | A. Nooka | H. Prince | C. Touzeau | E. Leip | B. Arnulf | M. Raab | J. Martínez-López | N. Bahlis | S. Manier | Y. Jethava | U. Conte | R. Niesvizky | G. Koehne | A. Viqueira | S. Sullivan | C. Maisel | P. Rodríguez Otero